This activity already occurred and is no longer available.
JNM (January 2012) Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
JNM, January 2012, Volume 53, Number 1

JNM (January 2012) Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

JNM, January 2012, Volume 53, Number 1

Member Fee: Free
Non-Member Fee: $15.00

Release Date: January 1, 2012
Expiration Date: January 31, 2015

Authors
Nicolaas I. Bohnen1–3, David S.W. Djang4, Karl Herholz5, Yoshimi Anzai6,7 and Satoshi Minoshima6

1Department of Radiology, University of Michigan, Ann Arbor, Michigan; 2Department of Neurology, University of Michigan, Ann Arbor, Michigan; 3VAMC, Ann Arbor, Michigan; 4Seattle Nuclear Medicine, Swedish Medical Center, Seattle, Washington; 5Wolfson Molecular Imaging Centre, University of Manchester, Manchester, England; 6Department of Radiology, University of Washington, Seattle, Washington; and 7Health Service Research, University of Washington, Seattle, Washington

Disclosure
In accordance with ACCME Revised Standards for Commercial Support and SNM Conflict-of-Interest Policy, the authors have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Target Audience
This article contains information of value to physicians practicing clinical nuclear medicine or clinical functional brain imaging with interest in brain imaging with 18F-FDG PET in neurodegenerative dementias.

Objectives
On successful completion of this activity, participants should be able to describe:

  1. The added diagnostic value of 18F-FDG PET in the assessment of dementia, compared with clinical assessment and follow-up alone.
  2. The physiologic basis of cerebral glucose metabolism and its pathologic alterations in neurodegeneration.
  3. Recent literature reports of potential contributions of 18F-FDG PET in Alzheimer disease assessment.
  4. The inclusion of biomarker evidence, including 18F-FDG PET, in new diagnostic criteria for Alzheimer disease.
  5. The impact of 18F-FDG PET on physician diagnostic confidence when assessing a patient with suspected dementia.

Continuing Education Credit Information

AMA-PRA (Physician)
The Society of Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: January 1, 2012. Expiration date: January 31, 2015.

 ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is TBD. Total available credit for pharmacists is 1.0 hours or 0.10 CEUs. Release Date: January 1, 2012. Expiration Date: January 31, 2015. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment.  You must obtain a score of 80% to receive the CE credit.  You will have no more than 3 attempts to successfully complete the post-test. Release Date: January 1, 2012. Expiration Date: January 31, 2015. California Scope: 1.0 Imaging(I).


Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (
http://get.adobe.com/reader/)

For questions please contact the Education Department at
Education@snmmi.org.

© 2014 SNMMI. All rights reserved.    Policy on Privacy and Confidentiality: http://www.snmmi.org/index.cfm?PageID=926 


Type:     Internet Activity (Enduring Material)
941 Registered Users